Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).

× No keyword cloud information.

21 in total

1. [Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].

Authors: Stefanie Strobl; Ina Zuber-Jerger
Journal: Med Klin (Munich) Date: 2010-04

2. Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.

Authors: Robert C Welsh; Cynthia M Westerhout; Christopher E Buller; Blair O'Neill; Phillip Gordon; Paul W Armstrong
Journal: J Thromb Thrombolysis Date: 2012-07 Impact factor: 2.300

3. Appropriate invasive and conservative treatment approaches for patients with ST-elevation MI.

Authors: Michelle O'Donoghue; Marc S Sabatine
Journal: Curr Treat Options Cardiovasc Med Date: 2006-02

4. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).

Authors: Shaheeda Ahmed; Elliott M Antman; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Harvey White; David A Morrow; Eugene Braunwald
Journal: J Thromb Thrombolysis Date: 2006-04 Impact factor: 2.300

5. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS).

Authors: Hendrik-Jan Dieker; Elvira V van Horssen; Ferry M R J Hersbach; Marc A Brouwer; Ad J van Boven; Arnoud W J van 't Hof; Wim R M Aengevaeren; Freek W A Verheugt; Frits W H M Bär
Journal: J Thromb Thrombolysis Date: 2006-08 Impact factor: 2.300

6. Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.

Authors: Rober C Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; Willian S Weintraub; Pierre Theroux
Journal: Can J Cardiol Date: 2009-12 Impact factor: 5.223

7. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.

Authors: C Michael Gibson; Yuri B Pride; Philip E Aylward; Jacques J Col; Shaun G Goodman; Dietrich Gulba; Mijo Bergovec; Vijayalakshmi Kunadian; Cafer Zorkun; Jacqueline L Buros; Sabina A Murphy; Elliott M Antman
Journal: J Thromb Thrombolysis Date: 2008-08-10 Impact factor: 2.300

Review 8. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.

Authors: Sergio Leonardi; Paul W Armstrong; Phillip J Schulte; E Magnus Ohman; L Kristin Newby
Journal: Eur Heart J Date: 2013-01-25 Impact factor: 29.983

Review 9. The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk.

Authors: David Fitchett
Journal: Can J Cardiol Date: 2007-06 Impact factor: 5.223

10. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events.

Authors: Keith A A Fox; Kathryn Carruthers; Ph Gabriel Steg; Alvaro Avezum; Christopher B Granger; Gilles Montalescot; Shaun G Goodman; Joel M Gore; Ann L Quill; Kim A Eagle
Journal: Eur Heart J Date: 2009-12-08 Impact factor: 29.983